# The Exploratory Study on the Baseline Level of NAD+/NADH in Peripheral Blood Samples of Different Gender and Age Groups of Healthy Adults.

> **NCT05997628** · — · UNKNOWN · sponsor: **Shanghai Cell Therapy Group Co.,Ltd** · enrollment: 60 (estimated)

## Conditions studied

- NAD+/NADH in Peripheral Blood Monitoring

## Interventions

- **OTHER:** Detection of NAD+/NADH concentration of Peripheral Blood Samples

## Key facts

- **NCT ID:** NCT05997628
- **Lead sponsor:** Shanghai Cell Therapy Group Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-05
- **Final completion:** 2024-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05997628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05997628, "The Exploratory Study on the Baseline Level of NAD+/NADH in Peripheral Blood Samples of Different Gender and Age Groups of Healthy Adults.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05997628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*